摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,3-二甲氧基丙基)-哌嗪 | 329217-27-8

中文名称
1-(2,3-二甲氧基丙基)-哌嗪
中文别名
——
英文名称
1-(2,3-dimethoxypropyl)piperazine
英文别名
——
1-(2,3-二甲氧基丙基)-哌嗪化学式
CAS
329217-27-8
化学式
C9H20N2O2
mdl
——
分子量
188.27
InChiKey
VXSDCSNXIDVDPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    13
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    33.7
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933599090

SDS

SDS:4102095e1174329b5d508d93c28d238a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    11-氯-二苯并[b,f][1,4]硫氮杂卓1-(2,3-二甲氧基丙基)-哌嗪 以 xylene 为溶剂, 反应 8.0h, 生成 11-[4-(2,3-Dimethoxy-propyl)-piperazin-1-yl]-dibenzo[b,f][1,4]thiazepine
    参考文献:
    名称:
    Behavioral Approach to Nondyskinetic Dopamine Antagonists:  Identification of Seroquel
    摘要:
    A great need exists for antipsychotic drugs which will not induce extrapyramidal symptoms (EPS) and tardive dyskinesias (TDs). These side effects are deemed to be a consequence of nonselective blockade of nigrostriatal and mesolimbic dopamine D2 receptors. Nondyskinetic clozapine (1) is a low-potency D2 dopamine receptor antagonist which appears to act selectively in the mesolimbic area. In this work dopamine antagonism was assessed in two mouse behavioral assays: antagonism of apomorphine-induced climbing and antagonism of apomorphine-induced disruption of swimming. The potential for the liability of dyskinesias was determined in haloperidol-sensitized Cebus monkeys. Initial examination of a few close cogeners of 1 enhanced confidence in the Cebus model as a predictor of dyskinetic potential. Considering dibenzazepines, 2 was not dyskinetic whereas 2a was dyskinetic. Among dibenzodiazepines, 1 did not induce dyskinesias where as its N-2-(2-hydroxyethoxy)ethyl analogue 3 was dyskinetic. The emergence of such distinctions presented an opportunity. Thus, aromatic and N-substituted analogues of 6-(piperazin-1-yl)-11H-dibenz[b,e]azepines and 11-(piperazin-1-yl)dibenzo[b,f][1,4]thiazepines and -oxazepines were prepared and evaluated. 11-(4-[2-(2-Hydroxyethoxy)ethyl]piperazin-1-yl)dibenzo[b,f][1,4]thiazepine (23) was found to be an apomorphine antagonist comparable to clozapine. It was essentially nondyskinetic in the Cebus model. With 23 as a platform, a number of N-substituted analogues were found to be good apomorphine antagonists but all were dyskinetic.
    DOI:
    10.1021/jm000242+
  • 作为产物:
    描述:
    1-(2,3-二甲氧基丙基)-4-苯基甲基哌嗪 在 10percent Pd/C 氢气 作用下, 以 乙醇 为溶剂, 50.0 ℃ 、344.75 kPa 条件下, 反应 1.5h, 以72%的产率得到1-(2,3-二甲氧基丙基)-哌嗪
    参考文献:
    名称:
    Behavioral Approach to Nondyskinetic Dopamine Antagonists:  Identification of Seroquel
    摘要:
    A great need exists for antipsychotic drugs which will not induce extrapyramidal symptoms (EPS) and tardive dyskinesias (TDs). These side effects are deemed to be a consequence of nonselective blockade of nigrostriatal and mesolimbic dopamine D2 receptors. Nondyskinetic clozapine (1) is a low-potency D2 dopamine receptor antagonist which appears to act selectively in the mesolimbic area. In this work dopamine antagonism was assessed in two mouse behavioral assays: antagonism of apomorphine-induced climbing and antagonism of apomorphine-induced disruption of swimming. The potential for the liability of dyskinesias was determined in haloperidol-sensitized Cebus monkeys. Initial examination of a few close cogeners of 1 enhanced confidence in the Cebus model as a predictor of dyskinetic potential. Considering dibenzazepines, 2 was not dyskinetic whereas 2a was dyskinetic. Among dibenzodiazepines, 1 did not induce dyskinesias where as its N-2-(2-hydroxyethoxy)ethyl analogue 3 was dyskinetic. The emergence of such distinctions presented an opportunity. Thus, aromatic and N-substituted analogues of 6-(piperazin-1-yl)-11H-dibenz[b,e]azepines and 11-(piperazin-1-yl)dibenzo[b,f][1,4]thiazepines and -oxazepines were prepared and evaluated. 11-(4-[2-(2-Hydroxyethoxy)ethyl]piperazin-1-yl)dibenzo[b,f][1,4]thiazepine (23) was found to be an apomorphine antagonist comparable to clozapine. It was essentially nondyskinetic in the Cebus model. With 23 as a platform, a number of N-substituted analogues were found to be good apomorphine antagonists but all were dyskinetic.
    DOI:
    10.1021/jm000242+
点击查看最新优质反应信息

文献信息

  • COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR SEPARATING CARBON DIOXIDE
    申请人:Tosoh Corporation
    公开号:EP4098348A1
    公开(公告)日:2022-12-07
    To provide a carbon dioxide separation composition which is excellent in carbon dioxide desorption efficiency (desorption amount/absorption amount) and durability to nitrogen oxides, and a method for separating carbon dioxide. A carbon dioxide separation composition, containing at least one amine compound selected from the group consisting of an amine compound represented by the following formula (1): wherein R1 to R3 each independently represent a hydrogen atom or a C1-4 alkyl group, and an amine compound represented by the following formula (2): wherein R10, R11, R12, R13 and R14 each independently represent a hydrogen atom, a C1-4 alkyl group, a hydroxy group, a hydroxymethyl group, a 2-hydroxyethyl group or a C1-4 alkoxy group, a and b are each independently 0 or 1 and satisfy the relation a+b=1, and R15 is a hydrogen atom, a C1-4 alkyl group, a methoxymethyl group, a methoxyethoxymethyl group or a 2-hydroxyethyl group.
    提供一种在二氧化碳解吸效率(解吸量/吸附量)和对氮氧化物的耐久性方面性能优异的二氧化碳分离组合物,以及一种分离二氧化碳的方法。 一种二氧化碳分离组合物,含有至少一种选自由下式(1)表示的胺化合物组成的组中的胺化合物: 其中R1至R3各自独立地代表氢原子或C1-4烷基,以及由下式(2)代表的胺化合物: 其中 R10、R11、R12、R13 和 R14 各自独立地代表氢原子、C1-4 烷基、羟基、羟甲基、2-羟乙基或 C1-4 烷氧基、 a 和 b 各自独立地为 0 或 1,并满足 a+b=1 的关系式,以及 R15 是氢原子、C1-4 烷基、甲氧基甲基、甲氧基乙氧基甲基或 2-羟乙基。
  • [EN] COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR SEPARATING CARBON DIOXIDE<br/>[FR] COMPOSITION POUR LA SÉPARATION DE DIOXYDE DE CARBONE ET PROCÉDÉ POUR SÉPARER DU DIOXYDE DE CARBONE<br/>[JA] 二酸化炭素分離用組成物、及び二酸化炭素の分離方法
    申请人:TOSOH CORP
    公开号:WO2021153650A1
    公开(公告)日:2021-08-05
    二酸化炭素の放散効率(放散量/吸収量)と窒素酸化物耐久性に優れた二酸化炭素分離用組成物、及び二酸化炭素の分離方法の提供。 下記一般式(1)[上記一般式(1)中、R1~R3は、各々独立して、水素原子、又は炭素数1~4のアルキル基を表す。]で示されるアミン化合物、及び下記一般式(2)[上記一般式(2)中、R10、R11、R12、R13及びR14は、各々独立して、水素原子、炭素数1~4のアルキル基、水酸基、ヒドロキシメチル基、2-ヒドロキシエチル基、又は炭素数1~4のアルコキシ基を表す。 a及びbは、それぞれ独立に、0又は1であり、a+b=1の関係を満たす。 R15は、水素原子、炭素数1~4のアルキル基、メトキシメチル基、メトキシエトキシメチル基、又は2-ヒドロキシエチル基を表す。] で示されるアミン化合物からなる群より選ばれる少なくとも一つのアミン化合物を含むことを特徴とする二酸化炭素分離用組成物を用いる。
  • Behavioral Approach to Nondyskinetic Dopamine Antagonists:  Identification of Seroquel
    作者:Edward J. Warawa、Bernard M. Migler、Cyrus J. Ohnmacht、Ann L. Needles、George C. Gatos、Frances M. McLaren、Cynthia L. Nelson、Karen M. Kirkland
    DOI:10.1021/jm000242+
    日期:2001.2.1
    A great need exists for antipsychotic drugs which will not induce extrapyramidal symptoms (EPS) and tardive dyskinesias (TDs). These side effects are deemed to be a consequence of nonselective blockade of nigrostriatal and mesolimbic dopamine D2 receptors. Nondyskinetic clozapine (1) is a low-potency D2 dopamine receptor antagonist which appears to act selectively in the mesolimbic area. In this work dopamine antagonism was assessed in two mouse behavioral assays: antagonism of apomorphine-induced climbing and antagonism of apomorphine-induced disruption of swimming. The potential for the liability of dyskinesias was determined in haloperidol-sensitized Cebus monkeys. Initial examination of a few close cogeners of 1 enhanced confidence in the Cebus model as a predictor of dyskinetic potential. Considering dibenzazepines, 2 was not dyskinetic whereas 2a was dyskinetic. Among dibenzodiazepines, 1 did not induce dyskinesias where as its N-2-(2-hydroxyethoxy)ethyl analogue 3 was dyskinetic. The emergence of such distinctions presented an opportunity. Thus, aromatic and N-substituted analogues of 6-(piperazin-1-yl)-11H-dibenz[b,e]azepines and 11-(piperazin-1-yl)dibenzo[b,f][1,4]thiazepines and -oxazepines were prepared and evaluated. 11-(4-[2-(2-Hydroxyethoxy)ethyl]piperazin-1-yl)dibenzo[b,f][1,4]thiazepine (23) was found to be an apomorphine antagonist comparable to clozapine. It was essentially nondyskinetic in the Cebus model. With 23 as a platform, a number of N-substituted analogues were found to be good apomorphine antagonists but all were dyskinetic.
查看更多